Sarah E. Maurrasse
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sarah E. Maurrasse has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Taher Valika
Division of Pediatric Otolaryngology‐Head and Neck Surgery Ann and Robert H. Lurie Children's Hospital of Chicago Chicago Illinois USA
7 shared publications Dana M. Thompson
Division of Pediatric Otolaryngology‐Head and Neck Surgery Ann and Robert H. Lurie Children's Hospital of Chicago Chicago Illinois USA
3 shared publications- Vikash K. Modi
Pediatric Otolaryngology, Department of Otolaryngology- Head & Neck Surgery, Weill Cornell Medical College, 428 East 72nd Street, New York, NY 10021, USA
3 shared publications - Abbey L. Landini
Northwestern University Feinberg School of Medicine Chicago Illinois USA
2 shared publications - Cyrus W. Abrahamson
Northwestern University Feinberg School of Medicine Chicago Illinois USA
2 shared publications David Spielberg
Department of Pediatrics‐Pulmonology Baylor University, Texas Children's Hospital Houston Texas USA
2 shared publications
Latest Publications
- 16 July 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (12) , E172-E173
In Response to Safety Profile of Nebulized Ciprofloxacin‐Dexamethasone After Pediatric Airway Surgery
- 16 July 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (12) , E172-E173
In Response to Safety Profile of Nebulized Ciprofloxacin‐Dexamethasone After Pediatric Airway Surgery
- Open Access
- 27 May 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (10) , 4514-4518
Safety Profile of Nebulized Ciprofloxacin‐Dexamethasone After Pediatric Airway Surgery
Objective: To evaluate the safety profile and patterns of use of nebulized ciprofloxacin–dexamethasone (CPD) in pediatric patients undergoing airway surgery. Methods: A retrospective chart review was performed of patients who underwent airway surgery at a tertiary pediatric center between 2019 and 2023 and received nebulized CPD 0.3%–0.1% postoperatively. Demographic, clinical, and procedural data were extracted. Exposure was defined as any postoperative nebulized administration. Adverse events were considered potentially CPD‐related if they occurred during administration or within 30 days of discontinuation without a better explanation. Outcomes included endocrine, metabolic, infectious, pulmonary, and inflammatory complications. Results: A total of 399 patients received nebulized CPD. Mean age was 46.2 months (range: newborn–20.7 years). Indications included subglottic stenosis (92.5%), post‐laryngotracheal reconstruction (5.3%), airway foreign body (2.0%), and supraglottoplasty (0.3%). Comorbidities were frequent, including neurologic conditions (47.6%), cardiac anomalies (41.6%), and bronchopulmonary dysplasia (25.1%). Most patients (93.4%) received CPD in the inpatient setting, for a mean duration of 11.7 days. No cases of adrenal suppression, glucose abnormalities, or bronchial hyperreactivity were identified. One patient had suspected airway fungal infection while receiving chemotherapy, though pathology was negative. Among the 85.7% of patients who underwent postoperative endoscopic evaluation, no significant inflammatory findings were observed. Conclusion: Nebulized CPD Was Uniformly Incorporated Into Postoperative Airway Management in This Large Pediatric Cohort and Well Tolerated, With no Significant Adverse Events Observed. These Findings Support the Safety of CPD in Medically Complex Children and Highlight the Need for Multicenter Prospective Studies to Evaluate Efficacy and Optimize Dosing Protocols. Level of Evidence: 3
- 27 May 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (10) , 4514-4518
Open AccessSafety Profile of Nebulized Ciprofloxacin‐Dexamethasone After Pediatric Airway Surgery
Objective: To evaluate the safety profile and patterns of use of nebulized ciprofloxacin–dexamethasone (CPD) in pediatric patients undergoing airway surgery. Methods: A retrospective chart review was performed of patients who underwent airway surgery at a tertiary pediatric center between 2019 and 2023 and received nebulized CPD 0.3%–0.1% postoperatively. Demographic, clinical, and procedural data were extracted. Exposure was defined as any postoperative nebulized administration. Adverse events were considered potentially CPD‐related if they occurred during administration or within 30 days of discontinuation without a better explanation. Outcomes included endocrine, metabolic, infectious, pulmonary, and inflammatory complications. Results: A total of 399 patients received nebulized CPD. Mean age was 46.2 months (range: newborn–20.7 years). Indications included subglottic stenosis (92.5%), post‐laryngotracheal reconstruction (5.3%), airway foreign body (2.0%), and supraglottoplasty (0.3%). Comorbidities were frequent, including neurologic conditions (47.6%), cardiac anomalies (41.6%), and bronchopulmonary dysplasia (25.1%). Most patients (93.4%) received CPD in the inpatient setting, for a mean duration of 11.7 days. No cases of adrenal suppression, glucose abnormalities, or bronchial hyperreactivity were identified. One patient had suspected airway fungal infection while receiving chemotherapy, though pathology was negative. Among the 85.7% of patients who underwent postoperative endoscopic evaluation, no significant inflammatory findings were observed. Conclusion: Nebulized CPD Was Uniformly Incorporated Into Postoperative Airway Management in This Large Pediatric Cohort and Well Tolerated, With no Significant Adverse Events Observed. These Findings Support the Safety of CPD in Medically Complex Children and Highlight the Need for Multicenter Prospective Studies to Evaluate Efficacy and Optimize Dosing Protocols. Level of Evidence: 3
- 5 October 2024
- Published by Wiley in The Laryngoscope
- Vol. 134 (12) , 4827-4831
Producing a High‐Quality Surgical Video
Producing high-quality surgical videos requires an understanding of cognitive theory and a working knowledge of film principles. In this editorial, we delve into pre-production, filming, and editing fundamentals that help create a professional product and highlight techniques to optimize knowledge acquisition through video content. image
- 5 October 2024
- Published by Wiley in The Laryngoscope
- Vol. 134 (12) , 4827-4831
Producing a High‐Quality Surgical Video
Producing high-quality surgical videos requires an understanding of cognitive theory and a working knowledge of film principles. In this editorial, we delve into pre-production, filming, and editing fundamentals that help create a professional product and highlight techniques to optimize knowledge acquisition through video content. image
- Open Access
- 18 January 2024
- Published by Wiley in The Laryngoscope
- Vol. 134 (7) , 3402-3405
The Airway Pocket: Novel Advancement in Endoscopic Submucosal Placement of Posterior Cartilage Graft
Endoscopic technology has increased our options for treatment of airway stenosis in a minimally invasive manner. This novel technique advances endoscopic posterior graft placement by creation of an airway pocket, potentially reducing risk of graft migration and improving outcomes. Laryngoscope, 2024.
- 18 January 2024
- Published by Wiley in The Laryngoscope
- Vol. 134 (7) , 3402-3405
Open AccessThe Airway Pocket: Novel Advancement in Endoscopic Submucosal Placement of Posterior Cartilage Graft
Endoscopic technology has increased our options for treatment of airway stenosis in a minimally invasive manner. This novel technique advances endoscopic posterior graft placement by creation of an airway pocket, potentially reducing risk of graft migration and improving outcomes. Laryngoscope, 2024.
- 1 January 2024
- Published by Springer Nature
- p. 13-24
Anatomy of the Neonatal Airway
- 27 December 2023
- Published by Wiley in The Laryngoscope
- Vol. 134 (6) , 2922-2930
Assessing National Trends and Perceived Safety of Off‐Label Ciprofloxacin‐Dexamethasone Use by Pediatric Otolaryngologists
Objectives: Off‐label use of Ciprodex® (ciprofloxacin‐dexamethasone: CPD), an antibiotic‐steroid combination solution, in the airway has been reported by pediatric otolaryngologists with anecdotal success. We examined national trends regarding off‐label CPD use including prevalence, common indications, prescriber patterns, adverse events, and accessibility. Methods: 15‐item cross‐sectional survey was distributed to American Society of Pediatric Otolaryngology members from January–April 2022. Univariate analyses were performed to compare responses for users of off‐label CPD versus non‐users. Ease of access was compared across geographies and practice types using multivariate logistic regressions. Results: Of the 163 complete responses (26.6% response rate), 156 (95.7%) reported using off‐label CPD. Most common indications for off‐label CPD were tracheal granulation (87.8%, n = 137) and choanal atresia (82.1%, n = 128). Ease of access was significantly increased in the Midwest (OR:18.79, 95%CI:3.63–1.24, p = 0.001) and West (OR:29.92, 95%CI:3.55–682.00, p = 0.006). Ease of access was significantly lower at tertiary referral centers (OR:0.11, 95%CI:0.01–0.64, p = 0.041) and private practices (OR:0.04, 95%CI:0.002–0.33, p = 0.009) compared to academic free‐standing children's hospitals. Two‐thirds of respondents reported feeling “Very Comfortable” with the safety profile of off‐label CPD; 99.4% ( n = 156) felt that the benefits outweighed the risks of off‐label use. Seven respondents (4.5%) reported adverse events (e.g., local allergic reaction, cushingoid symptoms) from off‐label use. Conclusions: Our findings (26.6% response rate) suggest that off‐label CPD is commonly used by pediatric otolaryngologists, many of whom reported feeling that the benefits of off‐label CPD outweigh the risks. Our results establish a baseline for future efforts to assess the efficacy and safety of off‐label CPD and to improve its accessibility. Level of Evidence: V Laryngoscope , 134:2922–2930, 2024
- 27 December 2023
- Published by Wiley in The Laryngoscope
- Vol. 134 (6) , 2922-2930
Assessing National Trends and Perceived Safety of Off‐Label Ciprofloxacin‐Dexamethasone Use by Pediatric Otolaryngologists
Objectives: Off‐label use of Ciprodex® (ciprofloxacin‐dexamethasone: CPD), an antibiotic‐steroid combination solution, in the airway has been reported by pediatric otolaryngologists with anecdotal success. We examined national trends regarding off‐label CPD use including prevalence, common indications, prescriber patterns, adverse events, and accessibility. Methods: 15‐item cross‐sectional survey was distributed to American Society of Pediatric Otolaryngology members from January–April 2022. Univariate analyses were performed to compare responses for users of off‐label CPD versus non‐users. Ease of access was compared across geographies and practice types using multivariate logistic regressions. Results: Of the 163 complete responses (26.6% response rate), 156 (95.7%) reported using off‐label CPD. Most common indications for off‐label CPD were tracheal granulation (87.8%, n = 137) and choanal atresia (82.1%, n = 128). Ease of access was significantly increased in the Midwest (OR:18.79, 95%CI:3.63–1.24, p = 0.001) and West (OR:29.92, 95%CI:3.55–682.00, p = 0.006). Ease of access was significantly lower at tertiary referral centers (OR:0.11, 95%CI:0.01–0.64, p = 0.041) and private practices (OR:0.04, 95%CI:0.002–0.33, p = 0.009) compared to academic free‐standing children's hospitals. Two‐thirds of respondents reported feeling “Very Comfortable” with the safety profile of off‐label CPD; 99.4% ( n = 156) felt that the benefits outweighed the risks of off‐label use. Seven respondents (4.5%) reported adverse events (e.g., local allergic reaction, cushingoid symptoms) from off‐label use. Conclusions: Our findings (26.6% response rate) suggest that off‐label CPD is commonly used by pediatric otolaryngologists, many of whom reported feeling that the benefits of off‐label CPD outweigh the risks. Our results establish a baseline for future efforts to assess the efficacy and safety of off‐label CPD and to improve its accessibility. Level of Evidence: V Laryngoscope , 134:2922–2930, 2024
- 12 July 2023
- Published by Wiley in The Laryngoscope
- Vol. 134 (2) , 977-980
Type 3 Laryngeal Clefts Presenting with Upper Airway Obstruction without Aspiration
Traditionally, otolaryngologists are taught that the defining clinical feature of a laryngeal cleft is aspiration. However, in a small subset of patients—even those with extensive clefts—the sole presenting feature may be airway obstruction. Here, we report two cases of type III laryngeal clefts that presented with upper airway obstruction without aspiration. The first patient was a 6‐month‐old male with history of tracheoesophageal fistula (TEF) who presented with noisy breathing, initially thought to be related to tracheomalacia. Polysomnogram (PSG) demonstrated moderate OSA and modified barium swallow (MBS) was negative for aspiration. In‐office laryngoscopy was notable for a mismatch of tissue in the interarytenoid region. A type III laryngeal cleft was identified on bronchoscopy, and airway symptoms resolved after endoscopic repair. The second patient was a 4‐year‐old male with a diagnosis of asthma who presented with progressive exercise‐induced stridor and airway obstruction. In‐office flexible laryngoscopy revealed redundant tissue in the posterior glottis and MBS was negative for aspiration. He was found to have a type III laryngeal cleft on bronchoscopy and his stridor and upper airway obstruction resolved after endoscopic repair. While aspiration is the most common presenting symptom of a laryngeal cleft, it is important to consider that patients can have a cleft in the absence of dysphagia. Laryngeal cleft should be included in the differential diagnosis for patients with obstructive symptoms not explained by other etiologies and in those with suspicious features on flexible laryngoscopy. Laryngeal cleft repair is recommended to restore normal anatomy and relieve obstructive symptoms. Laryngoscope, 134:977–980, 2024
- 12 July 2023
- Published by Wiley in The Laryngoscope
- Vol. 134 (2) , 977-980
Type 3 Laryngeal Clefts Presenting with Upper Airway Obstruction without Aspiration
Traditionally, otolaryngologists are taught that the defining clinical feature of a laryngeal cleft is aspiration. However, in a small subset of patients—even those with extensive clefts—the sole presenting feature may be airway obstruction. Here, we report two cases of type III laryngeal clefts that presented with upper airway obstruction without aspiration. The first patient was a 6‐month‐old male with history of tracheoesophageal fistula (TEF) who presented with noisy breathing, initially thought to be related to tracheomalacia. Polysomnogram (PSG) demonstrated moderate OSA and modified barium swallow (MBS) was negative for aspiration. In‐office laryngoscopy was notable for a mismatch of tissue in the interarytenoid region. A type III laryngeal cleft was identified on bronchoscopy, and airway symptoms resolved after endoscopic repair. The second patient was a 4‐year‐old male with a diagnosis of asthma who presented with progressive exercise‐induced stridor and airway obstruction. In‐office flexible laryngoscopy revealed redundant tissue in the posterior glottis and MBS was negative for aspiration. He was found to have a type III laryngeal cleft on bronchoscopy and his stridor and upper airway obstruction resolved after endoscopic repair. While aspiration is the most common presenting symptom of a laryngeal cleft, it is important to consider that patients can have a cleft in the absence of dysphagia. Laryngeal cleft should be included in the differential diagnosis for patients with obstructive symptoms not explained by other etiologies and in those with suspicious features on flexible laryngoscopy. Laryngeal cleft repair is recommended to restore normal anatomy and relieve obstructive symptoms. Laryngoscope, 134:977–980, 2024
- 5 August 2022
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 43 (5) , 103568
Assessing outcomes after partial and total tonsillectomy for sleep-disordered breathing in children using Clinical Assessment Score-15
- 5 August 2022
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 43 (5) , 103568
Assessing outcomes after partial and total tonsillectomy for sleep-disordered breathing in children using Clinical Assessment Score-15
- Open Access
- 1 March 2022
- Published by Elsevier in Otolaryngology Case Reports
- Vol. 22
An uncommon presentation of a parotid salivary duct cyst in a child
- 1 March 2022
- Published by Elsevier in Otolaryngology Case Reports
- Vol. 22
Open AccessAn uncommon presentation of a parotid salivary duct cyst in a child
- Open Access
- 1 November 2021
- Published by Elsevier in Otolaryngology Case Reports
- Vol. 21
Unilateral vocal cord paralysis due to meningoencephalitis in a pediatric patient
- 1 November 2021
- Published by Elsevier in Otolaryngology Case Reports
- Vol. 21
Open AccessUnilateral vocal cord paralysis due to meningoencephalitis in a pediatric patient